Study Finds Benefits to Second Peritoneal Mesothelioma Surgery
Patients with peritoneal mesothelioma cancer can survive considerably longer if they are willing and able to undergo a second aggressive surgery following tumor recurrence. History has proven that an incentive for a repeat surgery is there. A recent 30-year retrospective review at Wake Forest Baptist Medical Center has shown how beneficial the combination of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, or HIPEC, can be for several cancers with peritoneal metastasis. “People often think it’s a one-and-done procedure,” Wake Forest Baptist surgical oncologist Dr. Edward Levine told The M...
Source: Asbestos and Mesothelioma News - April 13, 2022 Category: Environmental Health Authors: Fran Mannino Tags: Clinical Trials/Research/Emerging Treatments Source Type: news

Appendiceal Cancer Up Among Younger Appendicitis Patients Appendiceal Cancer Up Among Younger Appendicitis Patients
A downside to treating appendicitis with antibiotics is that appendiceal cancer can be missed.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 29, 2022 Category: Consumer Health News Tags: General Surgery News Source Type: news

2004 to 2017 Saw Increase in Appendiceal Cancer
MONDAY, March 28, 2022 -- Incidence of appendiceal cancer increased from 2004 to 2017, particularly in patients ≤49 years of age, according to a study published online March 17 in the Journal of the American College of Surgeons. Michelle Salazar,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 28, 2022 Category: Pharmaceuticals Source Type: news

Personalized immunotherapy response studied in body-on-a-chip cancer models
(Wake Forest Baptist Medical Center) Wake Forest researchers and clinicians are using patient-specific tumor 'organoid' models as a preclinical companion platform to better evaluate immunotherapy treatment for appendiceal cancer, (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 19, 2021 Category: Cancer & Oncology Source Type: news

Study reveals distinct genomic landscape for young adults with appendiceal cancer
(Vanderbilt University Medical Center) The first study to compare molecular landscapes of early-onset and late-onset appendiceal cancer has revealed distinct non-silent mutations in the tumors of younger patients, setting the stage for the development of potential therapeutic advances for this rare disease. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 9, 2020 Category: Cancer & Oncology Source Type: news

Researchers develop first ever model for patient-specific treatment of appendix cancer
(Wake Forest Baptist Medical Center) Scientists at the Wake Forest Institute for Regenerative Medicine have recently developed a process that may change the way cancer of the appendix is treated in the future. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 17, 2018 Category: Cancer & Oncology Source Type: news

Medical News Today: What is appendix cancer?
Appendix cancer is very rare, and many people experience no symptoms in the early stages. Doctors often diagnose this cancer when it spreads to other organs or after they remove a person ’s appendix due to appendicitis. Learn more here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 11, 2018 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Genetic mutations of appendix cancer identified, may impact treatment
(University of California - San Diego) To understand why some patients with appendix cancer respond to standard treatment while others do not, University of California San Diego School of Medicine and Moores Cancer Center researchers, in collaboration with Foundation Medicine, performed genetic profiling on 703 appendiceal tumors -- the largest such study of this disease to date -- to compare mutations present in both cancer types. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 8, 2018 Category: Cancer & Oncology Source Type: news

2004 to 2017 Saw Increase in Appendiceal Cancer
Increase appears to be driven by a rise in carcinoids (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - October 12, 2017 Category: Cancer & Oncology Tags: Family Medicine, Gastroenterology, Internal Medicine, Oncology, Pathology, Surgery, Journal, Source Type: news

Time Between Surgeries Helps Predict Mesothelioma Survival
A new study from researchers at the City of Hope cancer center in Los Angeles and Wake Forest University School of Medicine in Winston-Salem, North Carolina, reveals how the length of time between initial and follow-up cytoreduction surgery and HIPEC plays a role in patient survival. The study, published in June in the Journal of Surgical Oncology, shows peritoneal mesothelioma patients who repeat the procedure between one and two years after the initial surgery have the most favorable outcome, with a median overall survival of nearly four years. Peritoneal mesothelioma is an aggressive, asbestos-related cancer, and recu...
Source: Asbestos and Mesothelioma News - June 23, 2017 Category: Environmental Health Authors: Matt Mauney Tags: appendiceal cancer city of hope cancer center colon cancer cytoreduction surgery debulking surgery Dr. Konstantinos Votanopoulos gastrointestinal cancer heated intraperitoneal chemotherapy HIPEC Journal of Surgical Oncology moffitt can Source Type: news

Review of appendix cancer cases finds over diagnosis
(University of California - San Diego) Lesions of the appendix are being over diagnosed as invasive cancer, report University of California San Diego School of Medicine researchers in a paper published June 7 in the journal PLOS ONE. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 7, 2017 Category: Cancer & Oncology Source Type: news